



New Dried Human Amniotic Membrane Is Useful 
as a Substitute for Dural Repair after Skull Base Surgery
We recently developed a novel dried human amniotic
membrane (AM, hyperdry amnion) that is processed using
far-infrared and microwave irradiation and then sterilized by
gamma-ray irradiation.7Wehave already begun to apply it to
ophthalmic treatment such as patch grafting on the ocular
surface in patients with corneal perforation and glaucoma
ﬁltering bleb leaks.8
In this study, we used dried human AM as an alternative to
autologous tissue for dural repair.We employed a ratmodel to
examine whether dried AM can be used for dural repair by
assessing histological changes in the implanted dried AM and
surrounding tissue over time. Additionally, the dried AMwas
used for dural repair after skull base surgery to determine its
efﬁcacy in preventing CSF leakage. This is the ﬁrst report of
clinical application of amniotic membrane as an intracranial
substitute for dura.
Material and Methods
Preparation of Dried Human Amniotic Membrane
Preparation of dried AM was a follows: fresh human AM was
obtained with the informed consent from donors who had
seronegative results for syphilis, human immunodeﬁciency
virus, human T-cell lymphoma virus type-1 (HTLV-1), and
hepatitis B and C viruses after caesarian sections performed in
Toyama University Hospital. The AM was washed with sterile
phosphate-buffered saline. The amniotic epithelial cell layer
was not removed. The AMs were dried consecutively under
low-air-pressure conditions, far-infrared, and microwave
irradiation at temperatures of less than 60°C using a hyperdry
device (Sakura, Nagano, Japan). Thereafter, the AM was cut
into 10-cm squares and vacuum packaged. For sterilization,
the packages were subjected to gamma-ray (25-kGy) irradia-
tion (►Fig. 1).
Evaluation of Efﬁcacy of Dried Human AM as Substitute
for Dura
Twenty adult male Wistar rats 14 weeks of age were studied
after anesthesia had been induced by intraperitoneal admin-
istration of sodium pentobarbital. In addition, local anesthe-
sia was maintained by inﬁltration of 1% lidocaine solution.
Following a midline sagittal incision, a right frontoparietal
craniotomy was performed using a surgical microscope and a
microdrill. A 5 ! 7 mm square piece of dura mater was
carefully excised so as not injure the underlying cortex. An
appropriate size of dried human AMwas placed on the cortex
covering the dural defect sufﬁciently without suturing in
16 animals (Dried AM group). In four animals, an expanded
polytetraﬂuoroethylene (PTFE) was implanted as a substitute
for dura in the same fashion (Control group). A piece of bone
wax was placed as bone substitute and the skin was sutured
with 2–0 silk.
At 2 weeks (four animals in the Dried AM group), 1 month
(four animals in the Control and four animals in the Dried AM
group), 3 months (four animals in the Dried AM group), and
6 months (four animals in the Dried AM group) after implan-
tation, immediate perfusion ﬁxation were performed in 4%
formalin solution after deep anesthesia had been induced by
intraperitoneal administration of an overdose of sodium pen-
tobarbital. The bone margin of the craniotomy, the dural graft
zone, and the subjacent brain were removed en bloc for
histological examination. The tissues were decalciﬁed with
formic acid and stainedwith hematoxylin-eosin and azan after
sectioning in thin layers. The care and use of experimental
animals was in accordance with institutional guideline.
Clinical Studies
Between December 2008 and May 2010, dried human AM
was used as a substitute for dura in 10 patients who under-
went skull base surgery at the Department of Neurosurgery,
University of Toyama, Toyama, Japan. Background patient
data are summarized in ►Table 1. All surgical procedures
were performed after patients had been informed of the risks
and alternative treatments, and each patient gave informed
consent. This study was approved by the Ethics Committee of
the University of Toyama.
Dried AM was cut to appropriate size and shape to ﬁt the
dural defect at the skull base. Several pieces of dried AMwere
placed in the dural defect (underlay technique) to cover the
inner surface of the dura. An overlay patch was then placed
over the dural defect (overlay technique). Fibrin gluewas used
to stick the dried AM to that placed in the dural defect and the
native dura mater. After packing the dead space with autolo-
gous fat grafts, vascularized fascial or pericranial ﬂaps, and
ﬁbrin glue, the craniotomy bone ﬂaps were ﬁxed in position
with titanium plates.
Figure 1 Macrographic (A) and histologic (B) appearance of the dried amniotic membrane (hematoxylin and eosin).
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略語集
AM          ：　ヒト羊膜（human amniotic membrane）
HD AM　：　ヒト乾燥羊膜（hyperdry human amniotic membrane）
ePTFE     ：　expanded polytetrafluoroethylene
CJD    　  :　クロイツフェルト・ヤコブ病（Creutzfeldt-Jakob Disease）
AIDS         :　後天性免疫不全症候群（Acquired immunodeficiency syndrome）
HIV    　   :　ヒト免疫不全ウイルス（Human Immunodeficiency Virus）
HTLV-1　：　ヒトT型リンパ好性ウイルス１型（Human T-lymphotropic Virus）
NK　　   ：　ナチュラルキラー（Natural Killer）
MHC　   ：　主要組織適合遺伝子複合体（major histocompatibility complex）
CT          ：　コンピュータ断層撮影（Computed Tomography）






Cerebrospinal fluid (CFS) leakage is an un-
desirable complication of skull base sur-
gery. We used dried human amniotic mem-
brane (AM) as a patch graft for dural repair 
to determine its eﬃcacy in preventing CSF 
leakage.
Design 
Frontoparietal craniotomy and removal of 
dura were performed in 20 Wistar rats. A 
dried AM was placed to cover the dural de-
fect without suturing in 16 animals. In four 
animals, an expanded polytetrafluoroethyl-
ene was implanted. At 2 weeks and 1, 3, 
and 6 months, histological examination 
was performed. Dried AM was also used 
as a substitute in 10 patients who under-
went skull base surgery, after approval by 
the Ethics Committee of the University of 
Toyama.
Results
At 2 weeks after implantation, thick con-
nective tissue completely enclosed the 
dried AM. At 1 month after implantation, 
the connective tissue became thin and the 
implanted AM shortened. At 3 and 6 
months after implantation, histological ex-
amination revealed disappearance of the 
dried AM and formation of membranous tis-
sue. In the clinical study, neither CSF leak-
age nor clinical adverse reaction directly 
related to the dried AM were observed. 
Conclusion
Dried human AM appears to be an ideal 






































































































layer と内葉 inner layerの二葉からなると
いわれるのはこのためである。大脳鎌や小
脳テントは固有硬膜が折り返すことで形成
される。また、固有硬膜 dura propria は髄





































































































1. Orbitozygomatic Infratemporal               
Approach
2. Otico-condylar Approach
3. Extensive Middle Fossa Approach
4. Anterior Transpetrosal-transtentorial     
Approach















































































































けた時期は 1979 年から 1991 年に及んで
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3%!-$52!  IS  INDICATED  FOR  USE  IN  THE  REPAIR  OF 
DURA MATER IN THE BRAIN




THE  AREA  WHERE  ARTIFICIAL  DURAL  MATER 
HAD  BEEN  USED  AND  THE  SUBSEQUENT 
REGENERATION OF NATURAL DURA MATER IN A 
RABBIT  !FTER    MONTHS  THE  SITE 
IMPLANTED WITH  3%!-$52!  $	 WAS 



















The tissue reaction was minimal 
and SEAMDURA had been com-
pletely absorbed after 24 weeks. 
Regeneration of the dura-like tissue 
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3%!-$52!  IS  IMMEDIATELY  TRANSPAR
ENT AND NON REFLECTIVE TO ENABLE A CLEAR 
LINE OF VIEW FOR THE .EUROSURGEON
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56, 57, 58, 59, 60, 61, 62, 63, 64,65。羊膜の低抗原性
を証明する実験で行われたボランティアへ




















































































波長域は 3μm ～1mm である。遠赤外線の








































We recently developed a novel dried human amniotic
membrane (AM, hyperdry amnion) that is processed using
far-infrared and microwave irradiation and then sterilized by
gamma-ray irradiation.7Wehave already begun to apply it to
ophthalmic treatment such as patch grafting on the ocular
surface in patients with corneal perforation and glaucoma
ﬁltering bleb leaks.8
In this study, we used dried human AM as an alternative to
autologous tissue for dural repair.We employed a ratmodel to
examine whether dried AM can be used for dural repair by
assessing histological changes in the implanted dried AM and
surrounding tissue over time. Additionally, the dried AMwas
used for dural repair after skull base surgery to determine its
efﬁcacy in preventing CSF leakage. This is the ﬁrst report of
clinical application of amniotic membrane as an intracranial
substitute for dura.
Material and Methods
Preparation of Dried Human Amniotic Membrane
Preparation of dried AM was a follows: fresh human AM was
obtained with the informed consent from donors who had
seronegative results for syphilis, human immunodeﬁciency
virus, human T-cell lymphoma virus type-1 (HTLV-1), and
hepatitis B and C viruses after caesarian sections performed in
Toyama University Hospital. The AM was washed with sterile
phosphate-buffered saline. The amniotic epithelial cell layer
was not removed. The AMs were dried consecutively under
low-air-pressure conditions, far-infrared, and microwave
irradiation at temperatures of less than 60°C using a hyperdry
device (Sakura, Nagano, Japan). Thereafter, the AM was cut
into 10-cm squares and vacuum packaged. For sterilization,
the packages were subjected to gamma-ray (25-kGy) irradia-
tion (►Fig. 1).
Evaluation of Efﬁcacy of Dried Human AM as Substitute
for Dura
Twenty adult male Wistar rats 14 weeks of age were studied
after anesthesia had been induced by intraperitoneal admin-
istration of sodium pentobarbital. In addition, local anesthe-
sia was maintained by inﬁltration of 1% lidocaine solution.
Following a midline sagittal incision, a right frontoparietal
craniotomy was performed using a surgical microscope and a
microdrill. A 5 ! 7 mm square piece of dura mater was
carefully excised so as not injure the underlying cortex. An
appropriate size of dried human AMwas placed on the cortex
covering the dural defect sufﬁciently without suturing in
16 animals (Dried AM group). In four animals, an expanded
polytetraﬂuoroethylene (PTFE) was implanted as a substitute
for dura in the same fashion (Control group). A piece of bone
wax was placed as bone substitute and the skin was sutured
with 2–0 silk.
At 2 weeks (four animals in the Dried AM group), 1 month
(four animals in the Control and four animals in the Dried AM
group), 3 months (four animals in the Dried AM group), and
6 months (four animals in the Dried AM group) after implan-
tation, immediate perfusion ﬁxation were performed in 4%
formalin solution after deep anesthesia had been induced by
intraperitoneal administration of an overdose of sodium pen-
tobarbital. The bone margin of the craniotomy, the dural graft
zone, and the subjacent brain were removed en bloc for
histological examination. The tissues were decalciﬁed with
formic acid and stainedwith hematoxylin-eosin and azan after
sectioning in thin layers. The care and use of experimental
animals was in accordance with institutional guideline.
Clinical Studies
Between December 2008 and May 2010, dried human AM
was used as a substitute for dura in 10 patients who under-
went skull base surgery at the Department of Neurosurgery,
University of Toyama, Toyama, Japan. Background patient
data are summarized in ►Table 1. All surgical procedures
were performed after patients had been informed of the risks
and alternative treatments, and each patient gave informed
consent. This study was approved by the Ethics Committee of
the University of Toyama.
Dried AM was cut to appropriate size and shape to ﬁt the
dural defect at the skull base. Several pieces of dried AMwere
placed in the dural defect (underlay technique) to cover the
inner surface of the dura. An overlay patch was then placed
over the dural defect (overlay technique). Fibrin gluewas used
to stick the dried AM to that placed in the dural defect and the
native dura mater. After packing the dead space with autolo-
gous fat grafts, vascularized fascial or pericranial ﬂaps, and
ﬁbrin glue, the craniotomy bone ﬂaps were ﬁxed in position
with titanium plates.
Figure 1 Macrographic (A) and histologic (B) appearance of the dried amniotic membrane (hematoxylin and eosin).
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ヒト乾燥羊膜 4.5 ± 1.3 














ヒト乾燥羊膜 1.25 ± 1.0 






















































1 70/F Chondrosarcoma Anterior transpetrosal 
approach
19 none
2 38/M Meningioma Orbitozygomatic approach 16 none
3 5/M Chordoma Anterior transpetrosal 
approach
6 transient
4 54/M Chondrosarcoma Anterior transpetrosal 
approach
6 none 
5 71/F Cavernoma Lateral suboccitipal 
approach
5 none
6 59/M Meningioma Orbitozygomatic approach 5 none


















































































































































































































































































































































































































canal wall down法 72施行時の修復、そし
て、歯科口腔外科での手術における組織欠
損部の修復において、効果的であることが
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